Monday, October 26, 2026 · Daily editionET --:--:--

Looking for volunteers

Impact of Intraoperative ICG on Functional Outc in RARP

NCT06446648 · University of California, Irvine · Updated 3 March 2026

What is being tested
ICG
For
Prostate Adenocarcinoma
Kind of study
Tests a treatment or device on volunteers. Early phase 1.
Who can join
Ages 18 years and older. About 400 people. The full rules are on the registry page.
Where
United States
When
Starts or started 12 July 2024, ends July 2030. Registered 6 June 2024.
Results
None posted yet.

In the researchers' words

This is a pilot, 3 phases open-label feasibility study with the 3rd phase consisting of randomized 2-arm intervention trial, to assess the systematic use of indocyanine green (ICG) in subjects with prostate adenocarcinoma during robot-assisted radical prostatectomy and its impact on sexual function outcomes at 12 months postoperatively.
ClinicalTrials.gov, NCT06446648

Sites

  • Chao Family Comprehensive Cancer Center University of California, IrvineOrange, California, United States